ANIK - Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal® Monovisc® and Orthovisc® | Benzinga
MONTREAL, May 16, 2024 /CNW/ - Pendopharm, a division of Pharmascience Canada ("Pendopharm"), is pleased to announce the renewal of its exclusive distribution agreement with Anika Therapeutics Inc (NASDAQ:ANIK) (Anika) for Cingal®, Monovisc® and Orthovisc® through the end of 2030.
Since 2012, Pendopharm has partnered with Anika, a global joint preservation company providing innovative & high-quality products therapeutic solutions to healthcare professionals and their patients.
"This partnership reinforces our shared commitment in restoring active living for Canadian patients" says ...